Reflow Medical, Inc. was founded with the core mission of developing simple yet sophisticated technologies to facilitate procedures for treating cardiovascular disease. The company focuses on creating innovative medical devices aimed at improving patient outcomes in the treatment of Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD). Their product lineup includes coraCatheters, Wingman, speX, spexLP, and Spur, all designed to enhance the effectiveness and safety of cardiovascular interventions.
Reflow Medical collaborates closely with leading physicians throughout the product development process, ensuring their technologies meet clinical needs and improve patient care. Notable achievements include the successful commercialization of multiple devices that have been well-received in the medical community. The company's impact is evident in its contribution to advancing cardiovascular treatment options, ultimately aiming to improve the quality of life for patients suffering from cardiovascular diseases.
